TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 72nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 73nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 107nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 116nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 122nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 128nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 132nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 138nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 177nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 246nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 309nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 436nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 465nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 601nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 605nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 650nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 926nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 934nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 985nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 1.01E+3nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 1.18E+3nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 1.25E+3nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 1.85E+3nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 1.86E+3nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 2.55E+3nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 3.09E+3nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 3.25E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 4.87E+3nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 5.03E+3nMAssay Description:Inhibition of human recombinant dopamine transporterMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 5.56E+3nMAssay Description:Inhibition of human recombinant 5HT transporterMore data for this Ligand-Target Pair
Affinity DataIC50: 6.02E+3nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 7.14E+3nMAssay Description:Inhibition of human recombinant norepinephrine transporterMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 7.80E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Sunovion Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 8.60E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 1.41E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair